Does AMIKACIN Cause Hepatic lesion? 12 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 12 reports of Hepatic lesion have been filed in association with AMIKACIN (ARIKAYCE). This represents 0.1% of all adverse event reports for AMIKACIN.
12
Reports of Hepatic lesion with AMIKACIN
0.1%
of all AMIKACIN reports
0
Deaths
4
Hospitalizations
How Dangerous Is Hepatic lesion From AMIKACIN?
Of the 12 reports, 4 (33.3%) required hospitalization.
Is Hepatic lesion Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for AMIKACIN. However, 12 reports have been filed with the FAERS database.
What Other Side Effects Does AMIKACIN Cause?
Cough (1,472)
Off label use (1,447)
Dyspnoea (1,367)
Hospitalisation (1,325)
Therapy interrupted (1,283)
Drug ineffective (1,275)
Death (1,005)
Dysphonia (914)
Product dose omission issue (677)
Fatigue (602)
What Other Drugs Cause Hepatic lesion?
OCTREOTIDE (296)
EVEROLIMUS (171)
RIBOCICLIB (144)
LETROZOLE (139)
CAPECITABINE (124)
ADALIMUMAB (123)
METHOTREXATE (108)
FULVESTRANT (107)
PALBOCICLIB (104)
CYCLOPHOSPHAMIDE (101)
Which AMIKACIN Alternatives Have Lower Hepatic lesion Risk?
AMIKACIN vs AMILORIDE
AMIKACIN vs AMILORIDE\HYDROCHLOROTHIAZIDE
AMIKACIN vs AMINO ACIDS
AMIKACIN vs AMINO ACIDS, SOURCE UNSPECIFIED
AMIKACIN vs AMINO ACIDS\ANHYDROUS DEXTROSE\CALCIUM\MAGNESIUM HEPTAHYDRATE\POTASSIUM\SODIUM\SODIUM GLYCEROPHOSPHATE ANHYDROUS\SOYBEAN OIL